PEMICU 2 HEPATOBILIER

67
PEMICU 2 HEPATOBILIER “ URINE ATAU TEH?” ALMIRA NABILA VALMAI 405130193

description

hepato

Transcript of PEMICU 2 HEPATOBILIER

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 1/67

PEMICU 2 HEPATOBILIER

“ URINE ATAU TEH?”

ALMIRA NABILA VALMAI

405130193

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 2/67

LO

1. Hepatt! "#a$

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 3/67

HEPATITIS VIRAL(A,B,C,D,E)

LO 1

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 4/67

HEPATITI% AA. DEFINISI Penyakit infeksi sistemik yang dominan menyerang hati akibat

masuknya virus hepatitis A (HAV) melalui transmisi fekal-oraldari makanan atau minuman yang telah terkontaminasi.

B. ETIOLOGI Virus RNA yang tergolong dalam famili pikornaviradae yang

 berukuran !-" mm dan tidak mempunyai selubung serta tahan

terhadap panas dan asam. #itemukan oleh  Peinstone pada tahun

$%!& dalam tin'a penderita.

C.EPIDEMIOLOG

I

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 5/67

D. GEJALA  Te#a!a &'#a() !e*at+ #a!a !a&t+ ,e-a-+ -'a$+&'#a() (a!' -a&a(+ pe#'t te#a!a &'#a() e(a&+ a#!e( /e#a#(a pe&at+ t(a p'at ,a( pe(a&t&'(() -ata ,a( &'$t -e(a, &'(().

E. RESIKOPENULARAN

O#a() a() /e$'- -e(,e#ta *epatt! A ,a( /e$'-

,"a&!(a! *epatt! A+ !a(ta! /'#'&+ ,ae#a*

pa,at+ pe())'(a 6/at+ *'/'()a( !e&!'a$ ,e()a(

6#a() te#(e&!.

F.PATOFISIOLOGI

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 6/67

G. DIAGNOSA • Be#,a!a#&a( )ea$a pa!e(

•  Te! ,a#a* a() -e('('&&a( a(t/6, I)M

te#*a,ap *epatt! A.

H.PEMERIKSAANLABORATORIUM

•g anti-HAV* infeksi akut+

•g, anti-HAV* infeksi lama+ imun terhadap HAV

•HAV-RNA* mendeteksi infektivitas

I.TATALAKSANA

• Te#ap !-pt6-at&•H,#a! a() a,e&'at•Be,#e!t

 J.PENCEGAHAN

•Va&!( HAV•Pe-/e#a( I-'(6)$6/'$( !e/e$'-7!ete$a*

paa(a(•%e$a$' -e(' ta()a( ,e()a( /a& ,e()a( !a/'(,a( a# -e()a$#•Hygiene perorangan yang baik 

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 7/67

Hepatt! B

• I(e&! "#'! *epatt! B -e#'pa&a( -a!a$a*&e!e*ata( ,'(a. %e/a(a& 2 'ta 6#a() ,!e$'#'* ,'(a te#(e&! "#'! (+ ,e()a( 450 'ta -e()a$a- (e&! &#6(&.

• %e/a(a& 500 'ta *())a 1 'ta pa!e(,e()a( *epatt! B -e(())a$ !etap ta*'((a.

• Hepatt! B -e('-/a() 80 pe(e/a/

te#a,(a &a#!(6-a *epat6!e$'$e# p#-e# ,a(-e(,','& pe#()&at &e,'a !ete$a* #6&6&!e/a)a pe(e/a/ &a(&e#.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 8/67

• V#'! *epatt! B -e#'pa&a( "#'! :NA a()te#-a!'& )6$6()a( Hepa,(a"#,ae+ a()

-e-p'(a e-pat /'a* 6pe( #ea,() #a-e ;(t+ &ap!'$+ p6$-e#a!e+ ,a( <.

• =e( (t -e()&6,e p#6te( ('&$e6&ap!, a()pe(t() ,a$a- -e-/'()&'! "#'! ,a( HBeA).

=e( pe#-'&aa( -e()&6,e p#6te( p#e>%1+ p#e>%2+ ,a( p#6te( %. =e( < -e()&6,e p#6te( <a() /e#pe#a( pe(t() ,a$a- p#6!e!&a#!(6)e(e!!.

• %a-pa !aat ( te#,apat ,e$apa( )e(6tpe "#'!*epatt! B ; )e(6tpe A+B+C+:+E++=+H. =e(6tpeB ,a( C pa$() /a(a& ,te-'&a( , a!a.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 9/67

I(e&! "#'! *epatt! B

• %e$a( t#a(!-! "e#t&a$+ "#'! *epatt! B ,apat,t#a(!-!&a( ,e()a( ee&t -e$a$' a#a(t'/'*+ pe#&'ta(+ ,a( -e$a$' -e-/#a( -'&6!a.

• V#'! *epatt! B 100 &a$ $e/* (e&!'! pa,apa!e( ,e()a( (e&! HIV ,a( 10 &a$ $e/*(e&!'! pa,a pa!e( *epatt! C.

• Pat6)e(e!! (e&! "#'! -e$/at&a( #e!p6(! -'(*'-6#a$ ,a( !e$'$a#. V#'! /e#ep$&a! , ,a$a-

*epat6!t+ ,-a(a "#'! te#!e/'t t,a& /e#!at!t6pat&. Re!p6( a(t/6, te#*a,ap a(t)e(pe#-'&aa( /e#pe#a( ,a$a- e$-(a! "#'!.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 10/67

=a-/a#a( &$(! (e&! "#'!

*epatt! B

• Ma!a (&'/a! "#'! *epatt! B a,a$a* 1>4 /'$a(.%ete$a* -a!a (&'/a!+ pa!e( -a!'& &e ,a$a- pe#6,ep#6,#6-a$+ ,e()a( )ea$a &6(!tt'!6(a$+ /e#'pa-a$a!e+ a(6#e&!a+ -'a$+ -'(ta)+ -a$)a+ ,a( -',a*

$e$a*.• Pa!e( ,apat -e()a$a- pe#'/a*a( #a!a pa,a (,#a

pe()eap ,a( pe#'/a*a( !e(!a! /a'>/a'a(. %e/a)a(pa!e( ,apat -e()a$a- (e# a/,6-e( &'a,#a( &a(a(ata! ata' (e# ep)a!t#'- (te#-te( a() #()a(

!a-pa -6,e#at.• :e-a- $e/* a#a() te#a, pa,a pa!e( ,e()a( (e&!

*epatt! B ,a( :+ /$a ,/a(,()a&a( ,e()a( (e&!*epatt! A ,a( .

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 11/67

=a-/a#a( &$(! ,a( pe('(a()(e&! "#'! *epatt! B a&'t

• Pa,a *epatt! B a&'t+ HB!A) -'('$ , !e#'-,a$a- a&t' 2>10 -())' !ete$a* papa#a("#'!. Pa,a !e/a)a( pa!e( ,ea!a+ HB!A)*$a() ,a$a- a&t' 4>@ /'$a(.

• A,a(a HB!A) a() pe#!!te( $e/* ,a# @ /'$a(-e('('&&a( /a*a pa!e( -e(,e#ta (e&!*epatt! B &#6(&.

• I)M a(t>HB -e#'pa&a( pe(a(,a !e#6$6)!pa$() pe(t() pa,a *epatt! B a&'t ,a(pe(a(,a !at'>!at'(a a() p6!t. Ba!a(a/e#ta*a( 4>@ /'$a( !e$a-a *epatt! a&'t.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 12/67

 Tata$a&!a(a (e&! *epatt!B a&'t

• I(e&! "#'! *epatt! B a&'t t,a& -e-/'t'*&a( a(t"#a$. Te#ap a() ,/e#&a( *a(a te#ap !'p6#t ,a( !-pt6-at&&a#e(a !e/a)a( /e!a# ,apat !e-/'* !p6(ta(.

• Pe(e)a*a( (e&! ,$a&'&a( -e$a$' "a&!(a!.

Pe(e)a*a( -e())'(a&a( -'(6)$6/'$( t,a& -e(e)a*(e&!+ -e$a(&a( -e()'#a() #e&'e(! pe(a&t &$(!.

• Va&!(a! *epatt! B te#,# ata! pa#t&e$ H/!A) a() t,a&te#)$&6!$a!+ (a-'( tetap t,a& ,apat ,/e,a&a( 6$e*t'/'* ,a# H/!A) (at'#a$.

• Pe-/e#a( ,$a&'&a( !ea#a (t#a-'!&'&a# , ,ae#a*,e$t6, !e/a(a& 3 &a$+ pa,a 0+ 1+ ,a( @ /'$a(. Pa!e(,e()a( &e*a-$a( t,a& -e(a,&6(t#a(,&a! '(t'&"a&!(a! (.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 13/67

Hepatt! #6(&

• Hepatt! &#6(& te#,# ata! ; 1. Hepatt! &#6(&pe#!!te(+ 2. Hepatt! &#6(& a&t+ 3. %#6!!*at

• Pa,a &e$a(a( *epatt! &#6(& pe#!!te(/a!a(a *a(a ,,apat&a( pe(())a( %=OT,a( %=PT a() t,a& te#$a$' *e/at.Ba!a(a%=OT ,a( %=PT -e(()&at 2>3 &a$ (6#-a$+

!e,a()&a( )a--a =T /a!a(a $e/* &e$ ,a#%=OT. 6!ata!e a$&a$+ =L:H+ CHE ,a( e(-&6a)'$a!-a!* ,a$a- /ata!>/ata! (6#-a$.P#6)(6!! pe(a&t ( /a!a(a /a&.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 14/67

• Pa,a *epatt! &#6(& a&t &e#'!a&a(*epat6!e$'$e#(a $e/* /e#at. %=OT ,a( %=PT ,apat-e(()&at !a-pa 5 &a$ ata' 10 &a$ , ata! a()&a(6#-a$. =a--a =T /a!a(a ,,apat&a( $e/*#e(,a* ,a# %=OT. Apa/$a &e#'!a&a( !e$ $e/* /e#at,apat p'$a ,te-'&a( pe(())a( =L:H.

• Pa,a !#6!! *at a&a( ,te-'&a( pe(())a( %=OT,a( %=PT a() !a()at /e#"a#a!. U-'-(a a&a(,,apat&a( =a--a =T $e/* t()) ,a# %=OT.Pe#/a(,()a( a(ta#a %=OT ,a( %=PT ata' #a!6 ,eRt! /a!a(a , ata! 1. 6$(e!te#a!e a&a(-e('#'( apa/$a &e#'!a&a( *at -a&( /e#at. E(-'(t'& pe-/e&'a( ,a#a* ')a a&a( -e('#'(.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 15/67

Hepatt! B &#6(&

• A,a(a pe#!!te(! "#'! *epatt! B $e/* ,a#@ /'$a(.

• Hepatt! B &#6(& -e#'pa&a( -a!a$a*

&e!e*ata( /e!a# te'ta-a , A!a+ ,-a(ate#,apat !e,,&t(a 5 ,a# !e$'#'*(a 300 'ta (,",' HB!A) p6!t -e(etap , !e$'#'*,'(a.

• %e/a(a& 15>25 pa!e( ,e()a( (e&! &#6(&*epatt! B -e(())a$ a&/at pe(a&t *at&#6(& a() ,!e/a/&a( 6$e* "#'! *epatt! B.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 16/67

• A,a 3 a!e pe(t() ,a$a- pe#a$a(a(

pe(a&t Hepatt! B &#6(& at' a!e-'(6t6$e#a(!+ a!e -'(6a&t ata'a!e --'(e$ea#a(e+ ,a( a!e

(6(#ep$&at ata' a!e #e!,'a$.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 17/67

Pat6)e(e!! pe#!!te(! VHB

• VHB -a!'& &e ,a$a- t'/'* !ea#a pa#e(te#a$. :a#pe#e,a#a( ,a#a* pa#t&e$ :a(e -a!'& &e ,a$a- *at,a( te#a, p#6!e! #ep$&a! "#'!.

• %e$a('t(a !e$ *at a&a( -e-p#6,'&! ,a(

-e(!e&#e! pa#t&e$ :a(e 't'*.• VHB -e#a()!a() #e!p6(! -'( t'/'*+ a() pe#ta-a

,#a()!a() a,a$a* #e!p6(! -'( (6(!pe!D&. P#6!e!e$-(a! (6(!pe!D& ( te#a, ,e()a(

-e-a(aat&a( !e$>!e$ N ,a( N>T.• U(t'& p#6!e! e#a,&a! VHB $e/* $a('t ,pe#$'&a(

#e!p6(! -'( !pe!D&+ at' ,e()a( -e()a&t"a! !e$$-6!t T ,a( !e$ $-6!t B.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 18/67

=a-/a#a( &$(!

• =a-/a#a( &$(! *epatt! B &#6(! !a()at /e#"a#a!.A,a a() ta(pa &e$'*a( ,a( !e/a)a( $a) ,,apat&a(*epat6-e)a$ ata' /a*&a( !p$e(6-e)a$. U-'-(a,,apat&a( &6(!e(t#a! /$#'/( a() (6#-a$.

• Hepatt! B &#6(& a() -a!* a&t ; HB!A) p6!t,e()a( :NA VHB $e/* ,a# 105 &6p7-$ ,,apat&a(&e$a(a( ALT a() -e(etap ata' (te#-te(. Pa,a /6p!*at+ ,,apat&a( )a-/a#a( pe#a,a()a( a() a&t.

• Ca##e# VHB (a&t ; HB!A) p6!t ,e()a( tte# :NA VHB

a() #e(,a* at' &'#a() ,a# 105 &6p7-$. 6(!e(t#a!ALT (6#-a$ ,a( pa,a pe-e#&!aa( *!t6$6)& te#,apat&e$a(a( a#()a( a() -(-a$.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 19/67

=a-/a#a( *!t6pat6$6)& *epatt! B

&#6(&

• Pa,a pa!e( *epatt! B &#6(& a#a() ,,apat&a()a-/a#a( &6$e!ta!!.

• =a-/a#a( *!t6pat6$6)& *epatt! B &#6(& ,/a) -e(a,3 &e$6-p6& ;

- Hepatt! &#6(& pe#!!te( a,a$a* (D$t#a! !e$>!e$-6(6('&$# pa,a ,ae#a* p6#ta$ ,e()a( !e,&t D/#6!!+$-t() p$ate -a!* 't'*+ t,a& a,a pee-ea$ (e&#6!!.=a-/a#a( !e#() ,,apat&a( pa,a a##e# a!-t6-at&.

- Hepatt! &#6(& a&t a,a$a* a,a(a (D$t#at #a,a() a()

-e(6(6$+ a() te#'ta-a te#,## ,a# $-6!t ,a( !e$p$a!-a a() te#,apat , ,ae#a* p6#ta$. Me(-/'$&a( e#6!$-t() p$ate ,a( ,!e#ta pee-ea$ (e&#6!!. =a-/a#a(( !e#() ta-pa& pa,a a##e# a() !a&t !-t6-at&.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 20/67

> Hepatt! &#6(& $6/'$a# !e#()

,(a-a&a( *epatt! a&'t/e#&epa(a()a(. :,apat&a()a-/a#a( pe#a,a()a( ,a( (e&#6!!

(t#a$6/'$a#+ t,a& te#,apatpee-ea$ (e&#6!! ,a( /#,)()(e&#6!!.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 21/67

 Tata$a&!a(a

• :&e(a$ 2 &e$6-p6& te#ap '(t'&*epatt! B &#6(& at' ;

- e$6-p6& -'(6-6,'$a! ;(te#e#6(+ t-6!( a$a 1+ "a&!(a!te#ap

- e$6-p6& te#ap a(t"#'! ;

$a-"',(+ a,e6"# ,p"6&!$

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 22/67

Hepatt! C

• Me#'pa&a( (e&! &#6(& te#!e#() a()-e('$a# -e$a$' ,a#a* , A-e#&a %e#&at!e&ta# 3.2 'ta

• a$a'p'( t,a& -e('$a# !ea#a !e&!'a$+!e!e6#a() a() #e!&6 (e&! -e$a$'(e&! (a#&6/a -'()&( -e-e#$'&a(pe#$a&'a( -e,! '(t'& pe(a&t -e('$a#

!e&!

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 23/67

HEPATITI% C

• A!a- ('&$eat ; !!RNA

• a-$; $a""#,ae

• =e('! ; Hepa"#'!

• :!e/'t *epatt! (6( A ,a( (6( B• E("e$6pe

•  T,a& ta*a( a!a- ,a( e-pe,'

•  T,a& ,te-'&a( ,a$a- t(a

• 80 p#6)#e! -e('' &#6(&

• Ma!a (&'/a! ; – >8 -)

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 24/67

• Ep,e-6$6) ;

 – T#a(!-! te#/a(a& /e#*'/'()a( ,e()a(

t#a('! ,a#a* te#'ta-a !e/e$'-,$a&'&a( pe(ap!a( ,6(6# ,a#a*

•  T#a(!-! ;

 – :a#a*

 – Mate#(a$ (e6(ata$

 – Pe())'(aa( a#'- !'(t& /e#!a-a

 – %e&!

 – 6(ta& ,e()a( pe(,e#ta

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 25/67

• =ea$a ; – A&'t ; -#p ,e()a( *epatt! "#'!

$a((a – #6(! ; )ea$a -(-a$ $e$a*+ -'a$+

-a$)a+ #a!a t,a& e(a& pa,a pe#'t&a(a( ata!+ )ata$>)ata$+ pe('#'(a( /e#at

/a,a(. :apat t-/'$ )ea$ae&!t#a*epat&

• :a)(6!! ;

 – A(t HCV F – HCV RNA F

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 26/67

Hepatt! C

P t # $ H tt

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 27/67

Pat"#!"$"% Hepatt!C Awalnya virus melekatkan diri pada reseptor spesifik di

membran sel hepar.

Virus berpenetrasi dan memasuki sitoplasma sel hepar.

Virus melepaskan kapsulnya dan terbentuk nukleokapsid.

Selanjutnya nukleokapsid menembus dinding sel hati danmemasuki inti sel.

 Asam nukleat virus akan keluar dari nukleokapsid dan

menempel pada DA.

DA akan merangsang hepar untuk membentuk protein dan

asam nukleat bagi virus.

!erbentuk virus baru dan akibat nekrosis sel-sel hati" maka

virus baru akan dilemparkan ke dalam peredaran darah.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 28/67

Fa&t"' '!&"

• :a#a* p#e,6-(a( ; IV:U ,a(pe(et#a! a#()a(+ #e!epe( p#6,'&,a#a*

•  T#a(!-! !e&!'a$ ; eD!e(! ,a#a*+#e&'e(! #e(,a*

• Mate#(a$>(e6(ata$ ; eD!e(! #e(,a*+

#e&'e(! #e(,a*•  Ta& te#,apat /'&t t#a(!-! e&a$>6#a$

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 29/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 30/67

Pee'&!aa Pe*+a%

A. AST (SGOT) ALT(SGPT)Aa$(a -e(()&at. :apat-e(()&at 1>2 -())'!e/e$'- &te#& &e-',a(ta-pa& -e('#'(.

B. Da'a- Le%&ap (DL)

C. De'e!a Da'a-Le%&ap

D. A$&a$ p-"!ata!eE.Fe!e!

F. A$/* Se'*

G. G*$a Da'a-

H. Ma!a P'"t'"/

I. B$'*/ !e'*

 J. Te! E&!'e! BSP(B'"!*$"pta$e)

K. B"p! Hat

L. S0a Hat

M.U'a$!a

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 31/67

Ha$ a% t2a& /"$e- 2$a&*&a pa2ape2e'ta a% e%a$a Hep3C

1. Ga()a( -e(,6(6#&a( ,a#a*+ a#()a( ata' 6#)a( t'/'*

2. H(,a# a$&6*6$ '(t'& -e$(,'() *at ,a# &e#'!a&a($e/* $a('t

3. La&'&a( te! $a/6#at6#'- !e!e#() a()

,#e&6-e(,a!&a( 6$e* ,6&te# '(t'& -e()'&'# &a,a#e(- *at ,a( '(t'& -e(,ete&! "#'! a() a&t ,a$a-,a#a*.

4. H(,a# -e-('- 6/at apap'( ta(pa /e#&6(!'$ta! pa,a,6&te# a(,a

5. :apat&a( "a&!( "#'! Hep>A ,a( Hep>B &a#e(a (e&!"#'! Hep>C t,a& /e#a!a$ ,a# /e(t'& *epatt! $a((a.

(e&! ,a# "#'! *epatt! $a((a ,apat -e-pe#/'#'&&e#'!a&a( *at

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 32/67

• I!t'a-at

• Det

• Me,&a-e(t6!a a() ,)'(a&a( ,a$a- pe()6/ata(Hepatt! C a,a$a*;• Interferon alfa

p#6te( a() ,/'at a$a- 6$e* t'/'* -a('!a '(t'&-e(()&at&a( !!te- ,aa ta*a( t'/'*7-'(ta! ,a( -e()at'#'()! !e$ $a((a.

• Pegylated interferon alfa:/'at ,) -e())a/'()&a( -6$e&'$ a() $a#'t a# ,!e/'t"polyethylene glycol (PEG)" ,) -6$e&'$ interferon alfa. $e/*

ee&t ,/a(,()&a( interferon alfa /a!a.• Ribavirin

6/at a() ,)'(a&a( /e#!a-a interferon alfa '(t'& pe()6/ata(Hepatt! C &#6(!. Ribavirin &a$a' ,pa&a t'())a$ t,a& ee&t+tetap ,) &6-/(a! interferon alfa+ $e/* ee&t inteferon alfa !e(,#.

Pe(ata$a&!a(aa(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 33/67

Ep,e-6$6) (e&! "#'! *epatt!

:

• :pe#&#a&a( te#,apat -(-a$ 15 'ta 6#a()te#(e&! H:V , !e$'#'* ,'(a ,e()a( a!'-! 5pe(),ap HBV te#(e&! 6$e* H:V.

• I(e&! H:V te#a, , !e$'#'* ,'(a ,e()a(

p#e"a$e(! t()) , A-e#&a %e$ata(+ A#&a Ba#at+ T-'# te()a*+ ,a( -e,te#a(a.

• #e&'e(! a() $e/* t()) te#a, pa,a a#ea t#6p!,a( !'/t#6p! a() -e-p'(a p#e"a$e(! (e&!

"#'! *epatt! B.• a#e(a ,a$a- 20 ta*'( te#a&*# (e&! "#'!

*epatt! B -'$a ,apat ,ta())'$a()+ -a&a (e&!*epatt! : ')a -e('#'( !ea#a !)(D&a(.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 34/67

%t#'&t'# "#'! *epatt! :

• V#'! *epatt! : -e#'pa&a( "#'! te#&e$+t,a& ,apat -e(e/a/&a( (e&! /$a t,a&,/a(t' ,e()a( (e&! HBV.

• H:V a,a$a* "#' /$66, /6#( !e*())ape('$a#a( te#a, !ea#a pa#e(te#a$.

• H:V a,a$a* "#'! RNA /e#,a-ete# 3@ --.Lap!a( $'a#(a a,a$a* HB!A) a()

-e-/'()&'a )e(6- RNA ,a( a(t)e(,e$ta. =e(6- ( te#,# ,a# 100('&$e6t,a #a(ta t'())a$ !#&'$a#+

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 35/67

Pat6)e(e!!

• O$e* &a#e(a ,/'()&'! HB!A) -a&aa#a -a!'&(a H:V &e ,a$a- !e$*at &e-'()&(a( /e!a# ')a

-e())'(a&a( #e!ept6# '(t'& HBV.• Pa,a pe(,e#ta ,e()a( (e&! H:V

&#6(! te#a, #ep$&a! (t#a!e$'$e#

a() *e/at ,-a(a pa,a &6(,! (/e/a( #ep$&a! "#'! a() t()),apat -e-/e# ee& $a()!'()

/e#'pa &e#'!a&a( !e$ *at !t6pat&.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 36/67

=a-/a#a( &$(!

• I&te#'! a() ,&'t ,e()a( pa(a!-e(,a,a&

• He-ate-e!!

• =ea$a )a)a$ *at '$-(a(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 37/67

Pe()6/ata( ,a(pe(e)a*a(

• Pe())'(aa( (te#e#6( a$a pa,ape(,e#ta H:V &#6(! -(-a$,$a&'&a( !e$a-a !at' ta*'(.

• Be$'- ,te-'&a( "a&!( H:V+(a-'( &a#e(a #ep$&a! H:V t,a&,apat te#a, ta(pa a,a(a (e&!

HBV -a&a -'(!a! te#*a,ap HBV ')a -e(e)a* te#a,(a (e&!H:V.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 38/67

HEPATITI% EA. DEFINISI Penyakit infeksi sistemik yang dominan menyerang hati akibat

masuknya virus hepatitis A (HAV) melalui transmisi fekal-oraldari makanan atau minuman yang telah terkontaminasi.

B. ETIOLOGI Virus RNA untai tunggal keil dengan diameter &-&nm dan

tidak berkapsul. #itularkan seara fekal-oral.

C.EPIDEMIOLOGI

Pa$() !e#() -e(e#a() '!a ,ea!a -',a>pe#te()a*a( ,e()a( a()&a -6#ta$ta! 1>2 ,a(20 pa,a a(ta *a-$.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 39/67

D. GEJALA K*'a% a!* a&a, *a$, *ta-,&e$e$a-a, e' pe'*t, 2ea, *' /e'4a'ape&at, t+a p*0at, e' !e2, +a*20e.

E. RESIKO

PENULARAN

A# -('- te#&6(ta-(a!+ !ataa( te#'ta-a &e

,ae#a* e(,e-! t()) HEV

F.PATOGENESIS

Ma!a (&'/a!+ a!e #ep$&a!+ a!e p#6)e!"ta!pe(a&t.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 40/67

Spt"!

ALT I%G at3HEV

I%M at3HEV

V'*! !t""$

5 1 6 7 8 9 : ; < = 15

11

16

17

Hepatt! E V'*!Ie0t"Tp0a$ Se'"$"%0

C"*'!e

Tte'

>ee&! ate'

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 41/67

G. DIAGNOSA • Be#,a!a#&a( )ea$a pa!e(

•  Te! ,a#a* a() -e('('&&a( a(t/6, Ite#*a,ap

*epatt! A.

H.PEMERIKSAANLABORATORIUM

•P/R reverse transription* deteksi RNA H0V dan H0V pada

spesimen tin'a dan hati

•g anti-H0V* titer yang meningkat bersifat simultan dengan

 peningkatan serum transaminase

•1iter g, anti-H0V* meningkat setelah resolusi ge'alaI.TATALAKSANA

• Te#ap !-pt6-at&•%'p6#t

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 42/67

HEPATITIS NON3VIRAL(NAFL, DRUG INDUCE,AUTOIMUN, GENETIK)

LO 6

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 43/67

Hepatt! A't6-'(

pe(a&t &#6(! ,-a(a !!te--'( t'/'* -e(e#a() &6-p6(e(ata' !e$ (6#-a$ ,a# *at !e*())a-e(e/a/&a( (a-a! ,a(&e#'!a&a( ,a# *epa#.

• L()&'()a(

• P#e,!p6!!)e(et&

*ttp;77.(,,&.(*.)6"7*ea$t*>(6#-at6(7*ea$t*>t6p!7$"e#>,!ea!e7a't6--'(e>

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 44/67

 Ta(,a ,a( =ea$a

• at)'e

• Uppe# a/,6-(a$ ,!6-6#t

• Ma$)a K At*#a$)a!

• :a##*ea

• Na'!ea

• C'!*()6, eat'#e!

• H#!'t!-

• Pa$$6#

• $6!! 6 appette

• pa( 6# ,!6-6#t 6"e# t*e $"e#

• !&( #a!*e!

• ,a#& e$$6 '#(e

• $)*t>6$6#e, !t66$!

•  a'(,e+ 6# e$$6() 6 t*e !&( a(, *te! 6 t*e ee!

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 45/67

Pe-e#&!aa(

• %e#'- a(t('$ea# a(t/6, ANA• A(t!-66t* -'!$e a(t/6, A%MA

• L"e#>&,(e -#6!6-a$ tpe 1 LM>1 a(t/6,

• %e#'- p#6te( e$et#6p*6# e!! %PEP

• 'a(ttat"e --'(6)$6/'$(!• B6p!

Ha!$ Pe-e#&!aa(• E$e"ate, !e#'- a-(6t#a(!e#a!e $e"e$!• E$e"ate, !e#'- --'(6)$6/'$( $e"e$!+ p#-a#$

--'(6)$6/'$( = I)=• %e#6p6!t"e #e!'$t! 6# ANA!+ %MA!+ 6# LM>1 6# a(t$"e#

t6!6$ 1 a(t>LC1 a(t/6,e!

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 46/67

Ha!$ B6p!

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 47/67

a#a&te#!t& $(! Hepatt!

A't6-'(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 48/67

 Tata$a&!a(a

• 6#t&6!te#6, B!a &6-/(a!,e()a( aat6p#(

•  T#a(!p$a(ta! *epa#

• :et ; a#a( (t#a"e(a '(t'& (a'!ea,a( "6-t()+ t()) &a$6#+ tetap&6(!'-! p#6te(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 49/67

:#')>I(,'e, Hepatt!

• A(a$)e!& a() -e()a(,'()a!eta-(6e(

• N%AI:

• A-6,a#6(e

• %te#6, a(a/6$&

• P$ B

• $6#p#6-a(

• E#t#6-!(

• Ha$6t*a(e

• Met$,6pa

• I!6(a,

• Met*6t#eJat

• %tat(!

• %'$a ,#')!

•  Tet#a$(e!

• A-6J$$(>$a"'$a(ate

• %6-e a(t>!e'#e -e,(e!

I(a-a! *epa# &a#e(a 6/at>6/at te#te(t' ,a$a- a()&apa(a() -a'p'( &a#e(a ,6!!a() /e#$e/*a(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 50/67

 Ta(,a ,a( =ea$a

• at)'e

• A/,6-(a$ pa(

• :a##*ea

• :a#& U#(e

• e"e#

• Hea,a*e

•  Ga'(,e

• Na'!ea a(, "6-t()

• Ra!*

• *te 6# $a>6$6#e, !t66$!

• L6!! 6 Appette

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 51/67

Pe-e#&!aa(

• E(- *at -e(()&at

• Hepat6-e)a$ *epa# -e-/e!a#

• Ne# te&a( &'a,#a( &a(a( ata!

 Tata$a&!a(a K Pe(e)a*a(

• %t6p -e-('- 6/at a() -e(e/a/&a( *epatt!•  Ga()a( -e-('- 6/at -e$e/* ,6!! a() ,!a#a(&a(

•  Ga()a( -e-('- 6/at !ea#a te#'! -e(e#'! ta(pa /e#&6(!'$ta!,e()a( ,6&te#

• Be#ta*' &epa,a ,6&te# te(ta() 6/at>6/ata( a() a(,a -('-

&*'!'!(a a() -e()a(,'() a!eta-(6e( ,a( ata' p*e(t6(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 52/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 53/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 54/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 55/67

NAL:

• NAL: N6(>a$6*6$ att L"e#:!ea!e! a,a$a* &e$a(a( *at -#p,e()a( pe(a&t *at a$&6*6$& a()

te#a, pa,a !e!e6#a() /'&a(pe-('- a$&6*6$+ ,e()a( !pe&t#'-&e$a(a( *at -e$p't pe#$e-a&a( *at

!aa !-p$e !teat6!!+ pe#$e-a&a(,e()a( &e#a,a()a( *at NA%H+!a-pa ,e()a( D/#6!! ,a( !#6!!.

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 56/67

• Bata!a( ($a ata! ,a# (6( a$&6*6$&a,a$a* '-$a* &6(!'-! a$&6*6$'(t'& a(ta 20 )#a-7*a# ,a( '(t'&

$a&>$a& 30 )#a-7*a#.• NAL: -e#'pa&a( -a(e!ta! *at

,a# !(,#6- -eta/6$& 6/e!ta!+

*pe#te(!+ ,a/ete!+*pe#t#)$!e#,e-a+ ,a( &a,a# H:L#e(,a*

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 57/67

%(,#6- -eta/6$&

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 58/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 59/67

$a!D&a! NAL:Cate%"

'

Pat-"$"% C$0"pat-"$"%0

C"''e$at"! Tpe 1 %-p$e !teat6!! (6( t6 /e (6(p#6)#e!!"e

 Tpe 2 %teat6!! p$'! $6/'$a#(a--at6(

P#6/a/$ /e()( (6t6(!,e#e, t6 /e NA%H

 Tpe 3 %teat6!!+ $6/'$a#

(a--at6(+ a(, /a$$66((),e)e(e#at6(

NA%H t*6't D/#6!! -a

p#6)#e!! t6 ##*6!! a(, $"e#a$'#e

 Tpe 4 %teat6!!+ /a$$66((),e)e(e#at6(

NA%H t* D/#6!! -ap#6)#e!! t6 ##*6!! a(, $"e#a$'#e

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 60/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 61/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 62/67

Pe-e#&!aa(

• La/

- A!pa#tate a-(6t#a(!e#a!e A%T

- A$a((e a-(6t#a(!e#a!e ALT

- =a--a =$'ta-$ T#a(!pept,a!e ==T

- A$/'-(

- B$#'/(

- I(te#(at6(a$ (6#-a$e, #at6 INRPT

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 63/67

• Pe(t#aa(

- U$t#a!6(6)#aD U%=  /#)*t $"e#

- C6-p'te#e, T6-6)#ap* !a( CT!a(

- Ma)(et Re!6(a(e I-a)() MRI.

 

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 64/67

:e#aat pe#$e-a&a( *at !ea#a U%=

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 65/67

 Tata$a&!a(a

• N6( a#-a&6

- Me-pe#/a& )aa *,'p&'#a()/e#at /a,a(

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 66/67

7/17/2019 PEMICU 2 HEPATOBILIER

http://slidepdf.com/reader/full/pemicu-2-hepatobilier 67/67

6-p$&a!